ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Provided By PR Newswire
Last update: Jun 2, 2025
LAUSANNE, Switzerland, June 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 107,550 of the Company's common shares to two new employees on June 2, 2025 (each, a "Grant").
Read more at prnewswire.com
